RAVELLI, Cosetta
 Distribuzione geografica
Continente #
NA - Nord America 2.670
EU - Europa 2.611
AS - Asia 1.223
SA - Sud America 18
OC - Oceania 14
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.544
Nazione #
US - Stati Uniti d'America 2.648
PL - Polonia 1.202
IT - Italia 487
CN - Cina 418
SG - Singapore 318
UA - Ucraina 256
HK - Hong Kong 236
DE - Germania 168
FI - Finlandia 96
GB - Regno Unito 91
VN - Vietnam 66
TR - Turchia 65
IE - Irlanda 62
RU - Federazione Russa 62
IN - India 42
BE - Belgio 34
FR - Francia 34
ID - Indonesia 30
ES - Italia 25
CZ - Repubblica Ceca 21
NL - Olanda 21
SE - Svezia 17
CA - Canada 15
BR - Brasile 10
JP - Giappone 10
AT - Austria 8
AU - Australia 8
PH - Filippine 7
EE - Estonia 6
GR - Grecia 6
NZ - Nuova Zelanda 6
AR - Argentina 4
CH - Svizzera 4
IR - Iran 4
KR - Corea 4
PK - Pakistan 4
EG - Egitto 3
RO - Romania 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EU - Europa 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MX - Messico 2
MY - Malesia 2
ZA - Sudafrica 2
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
IS - Islanda 1
MA - Marocco 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
Totale 6.544
Città #
Warsaw 1.202
Fairfield 310
Brescia 249
Hong Kong 234
Ashburn 223
Singapore 221
Jacksonville 211
Woodbridge 192
Ann Arbor 190
Chandler 180
Seattle 127
Wilmington 123
Houston 116
Princeton 114
Cambridge 111
Dearborn 100
Helsinki 69
Dong Ket 63
Nanjing 62
Beijing 61
Dublin 58
Istanbul 58
Milan 57
New York 56
Shanghai 32
Brussels 31
Shenyang 31
Jakarta 29
Nanchang 26
Jinan 23
Moscow 23
Changsha 22
Des Moines 22
Madrid 22
San Diego 20
Hebei 19
Los Angeles 19
London 18
Munich 16
Boardman 12
Guangzhou 12
Haikou 12
Olomouc 12
Rome 11
Tianjin 11
Fara Gera d'Adda 10
Toronto 10
Amsterdam 9
Augusta 9
Nuremberg 9
Phoenix 9
Washington 9
Hangzhou 8
Hefei 8
Jiaxing 8
Kunming 8
San Francisco 8
Zhengzhou 8
Romola 7
San Mateo 7
Brno 6
Kilburn 6
Padova 6
Salò 6
Taizhou 6
Tallinn 6
Lanzhou 5
Linköping 5
Naples 5
Redwood City 5
Sant'angelo Lodigiano 5
Tokyo 5
Auckland 4
Frankfurt am Main 4
Islamabad 4
Lappeenranta 4
Melbourne 4
Napoli 4
Nottingham 4
Orange 4
Pune 4
Quartu Sant'elena 4
San Giovanni Rotondo 4
Verona 4
Angeles City 3
Bagnolo Mella 3
Chennai 3
Chiswick 3
Detroit 3
Fuzhou 3
Gunzenhausen 3
Lancaster 3
Larissa 3
Leawood 3
Leeds 3
Lubbock 3
Marigliano 3
Monmouth Junction 3
Nashville 3
Newark 3
Totale 5.099
Nome #
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 260
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 245
Claudin3 is localized outside the tight junctions in human carcinomas 237
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 235
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 233
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 221
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 220
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 219
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 218
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 176
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 171
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 163
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 146
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 144
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 137
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 134
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 126
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 124
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 123
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 113
Insights on the receptor dynamics during the spreading of endothelial cells 105
Vascular disrupting activity of combretastatin analogues 98
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 96
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 95
Simulation of VEGF receptor recruitment on ECs membrane 93
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 90
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 84
Role of VEGFs in metabolic disorders 84
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 83
Role of VEGFR2 co-receptors in the modulation of the pro-angiogenic activity of gremlin. 82
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 81
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 81
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 79
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 78
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 78
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 77
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 72
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 72
Molecular insight on the altered membrane trafficking of TrkA kinase dead mutants 71
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 70
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 69
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 68
Heparan-sulfate proteoglycans mediate the angiogenic activity of the novel VEGFR2 agonist gremlin 68
VEGFR2 recruitment and activation by substrate-immobilized VEGF 68
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation 67
Modeling cell motility and receptor dynamics 66
VEGFR2 recruitment and activation by substratum-immobilized gremlin 65
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types 64
VEGFR2 RECRUITMENT AND ACTIVATION BY SUBSTRATE-IMMOBILIZED DRM/GREMLIN 63
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 61
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 61
Identification and characterization of pro-oncogenic low frequency VEGFR2 mutations 57
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 51
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 45
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 43
The contribution of obesogenic behavior on global warming 40
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 38
The Extracellular Matrix modulates mechanotransduction and metabolic alteration in EC leading to melanoma vascularization 37
Role of gremlin-1 in the pathophysiology of the adipose tissues 37
Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes 36
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 34
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants 32
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 30
Mechanobiology of the relocation of proteins in advecting cells: in vitro experiments, multi-physics modeling, and simulations 30
The D647N mutation of FGFR1 induces ligand-independent receptor activation 28
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 27
FGF-trapping hampers cancer stem-like cells in uveal melanoma 27
Alternative method to visualize receptor dynamics in cell membranes 23
Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics 21
Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1 21
The impact of adipokines on vascular networks in adipose tissue 17
Totale 6.708
Categoria #
all - tutte 31.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020490 0 0 0 0 0 0 0 0 124 199 87 80
2020/20211.080 40 87 69 121 78 105 56 110 119 95 107 93
2021/2022531 30 72 9 10 23 42 33 38 41 77 35 121
2022/2023552 82 45 27 29 50 111 13 58 76 9 20 32
2023/2024756 44 33 70 61 55 104 28 61 125 46 19 110
2024/20251.018 46 13 29 262 171 117 150 82 148 0 0 0
Totale 6.708